Stefan Wampl1, Ladislav Valkovic2, Ferenc Mozes2, Martin Meyerspeer1, and Albrecht Ingo Schmid1
1High Field MR Center, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria, 2Oxford Centre for Clinical MR Research, RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom
Synopsis
Keywords: Heart, Spectroscopy, 31P MRS
To
demonstrate reproducibility of cardiac 31P MR spectroscopy at 7T,
three subjects were scanned on two sites in two different countries.
The two sites are equipped with similar MR scanners but scanner
platform versions, RF coil hardware and operators differed. The
16-channel receive array at site A provided 50% higher SNR than the
14cm single loop coil at site B, while site B achieved better
linewidths, resulting in similar quality of spectral fitting. Two
scan protocols were compared between the sites, both provided good
reproducibility of cardiac PCr/ATP. This demonstrates the feasibility
of larger multi-centre trials of cardiac MR spectroscopy.
Introduction
Cardiac
phosphorus-31 (31P) magnetic resonance spectroscopy (MRS) provides markers of
myocardial disease [1,2]. The heart’s small size and deep location
in the chest incur low SNR. High static magnetic fields like 7 T help
remedy this, as does using array coils. It is therefore even more
important than usual to test the reproducibility of the method.Methods
The
study was conducted in accordance to the Declaration of Helsinki in
its latest form and with approval of both sites’ Ethics Boards.
Part 1: comparison of sites. Three
subjects
(3m, 33-46
years, BMI
22.4±1.3
kg/m²)
were scanned
in two different
7 T scanners (Siemens Healthineers, Germany) in two countries within
27
days each.
Site A: Scanner platform version Syngo VE12, 14 cm single-loop
transmit-receive coil, default
cardiac shim; site B: Syngo
VB17, single channel transmit, 16 channel receive array coil, tune-up
shim. Both coils were
manufactured by RAPID Biomedical, Rimpar, Germany. The 31P MRS protocols used were 3D k-space weighted CSI 8x16x8:
(I) protocol “short”, untriggered, scan time 6.6 min, as
described previously [3], and (II) protocol “long”, triggered,
acquisition during end-systole, scan time site A: 18.0±2.3, site
B:17.2±0.1 min as in [4]. Acquisitions were performed by three
operators with several years experience in cardiac 31P MRS.
Part 2: longitudinal comparison. Four subjects (1f, 26-46 years, BMI 22.1±1.2
kg/m²) were invited twice with more than 260 days between measurements using the protocol "long" at site A.
All spectra
were processed and quantified by the same person in MATLAB (Mathworks,
USA) using the OXSA toolbox [5]. Voxel-wise flip angle estimations
were determined using an external reference, as described previously
[6]. The PCr to ATP ratio was quantified for partial T1 saturation
and blood contribution based on DPG/ATP [7].
Two
voxels in the interventricular septum in two CSI slices were selected
and analyzed in each scan. Voxels were selected on datasets from both
days with similar locations and compared in a Bland-Altmann plot. Coefficient of variation was calculated.
3-way ANOVA was performed to
test for paired differences
between sites, protocols and voxel positions.Results
Part 1, site comparison: Data
quality was very good on both sites, as can be seen from Figure 1,
even inorganic phosphate next to 2,3-DPG can be fitted. One voxel
result had to be discarded due to SNR of PCr <10. The data from
site B, acquired with the 16-channel array, showed 50 % (p=0.04)
higher SNR than site A with the single loop coil. Overall, CRLBs of
PCr/ATP were similar with 0.14±0.06 (site A) and 0.12±0.04 (site
B), p=0.30, compensated by a better shim at site A. PCr/ATP was
reproducible between sites with 1.35±0.31 (site A) and 1.57±0.49
(site B), p=0.16 (see Figure 2), and a coefficient of variation of 26%.
No differences in PCr/ATP were found between the two protocols
(short: 1.47±0.39, long: 1.45±0.37, p=0.88), however, the long
protocol provided significantly better fitting quality
(CRLB=0.10±0.03) than the short protocol (CRLB=0.16±0.05, p=0.007).
No differences were found for selected voxel position (p=0.94).
Part 2, longitudinal comparison: Good reproducibility was found for repeated measurements after a pause > 260 days between sessions (see Figure 3). No difference in PCr/ATP was found between measurements at different dates (day 1: 1.57±0.45, day 2: 1.50±0.20, p=0.67) or voxels (anterior: 1.67±0.40, posterior: 1.40±0.23, p=0.11). Coefficient of variation between measurement days was 36%.Discussion & Conclusion
We
show that 7 T cardiac 31P MRS is reproducible when using different
hardware and scanner platform versions. The triggered, longer
protocol has several advantages despite the longer scan time. The SNR
is higher even in deeper locations, so more voxels can be analysed,
and also Pi is more readily detected [4].
This multi-center and multi-operator comparison revealed several
of the intricacies related to performing cardiac 31P MRS, while still
presenting good reproducibility of PCr/ATP. Particular care was taken
to use the same 31P MRS protocols and evaluation methods. However,
differences in overall scan execution (e.g. patient setup, coil
positioning, CSI grid positioning, shimming procedure) were apparent.
Especially the selection of voxels from anatomically similar regions
between the sites was challenged by varying quality of cardiac
localizers. Also, optimal shimming approaches differed for the two
sites (cardiac shim at site A vs. tune-up shim at site B) affecting linewidths and CRLBs.
The experience gained from this small cohort could stimulate
further harmonization of cardiac 31P MRS protocols to boost its
clinical relevance. More subjects are currently being recruited to
confirm these preliminary findings.
To conclude, a larger multi-center trial of cardiac 31P MRS should
be performed to underline its clinical feasibility.Acknowledgements
This
work was supported by the Austrian Science Fund (FWF) project P
28867.References
[1]
Bizino MB, et al. Heart 2014;100:881–890.
doi:10.1136/heartjnl-2012-302546
[2] Neubauer S, et al. NEJM 2007;356(11), 1140–1151.
doi:10.1056/NEJMra063052
[3] Ellis J, et al. NMR Biomed 2019;32(6), e4095.
doi:10.1002/nbm.4095
[4] Wampl S, et al. Sci Rep 2021;11(1), 9268.
doi:10.1038/s41598-021-87063-8
[5] Purvis LA et al. PLOS ONE 2017;12(9), e0185356.
doi:10.1371/journal.pone.0185356
[6] Rodgers CT, et al. MRM 2014;72(2), 304–315.
doi:10.1002/mrm.24922
[7] Valkovič L, et al. JCMR 2019;21(1), 19.
doi:10.1186/s12968-019-0529-4